CHEBI:178196 - oncrasin-1

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name oncrasin-1
ChEBI ID CHEBI:178196
Definition A member of the class of indoles that is 1H-indole substituted by 4-chlorobenzyl and formyl groups at positions 1 and 3, respectively. It is an anti-cancer agent that is active against lung cancer cells with K-Ras mutations.
Stars This entity has been manually annotated by the ChEBI Team.
Submitter Ceara Rea
Supplier Information
Download Molfile XML SDF
Formula C16H12ClNO
Net Charge 0
Average Mass 269.730
Monoisotopic Mass 269.06074
InChI InChI=1S/C16H12ClNO/c17-14-7-5-12(6-8-14)9-18-10-13(11-19)15-3-1-2-4-16(15)18/h1-8,10-11H,9H2
InChIKey ZDRQMXCSSAPUMM-UHFFFAOYSA-N
SMILES [H]C(=O)C1=CN(CC2=CC=C(Cl)C=C2)C2=CC=CC=C12
Roles Classification
Biological Role(s): apoptosis inducer
Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.
Application(s): antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing oncrasin-1 (CHEBI:178196) has role antineoplastic agent (CHEBI:35610)
oncrasin-1 (CHEBI:178196) has role apoptosis inducer (CHEBI:68495)
oncrasin-1 (CHEBI:178196) is a arenecarbaldehyde (CHEBI:33855)
oncrasin-1 (CHEBI:178196) is a indoles (CHEBI:24828)
oncrasin-1 (CHEBI:178196) is a monochlorobenzenes (CHEBI:83403)
IUPAC Name
1-(4-chlorobenzyl)-1H-indole-3-carbaldehyde
Synonyms Sources
1-(p-chlorobenzyl)-1H-indole-3-carbaldehyde ChEBI
1-[(4-chlorophenyl)methyl]-1H-indole-3-carbaldehyde IUPAC
ONC-1 ChEBI
oncrasin 1 ChEBI
Manual Xrefs Databases
761753 ChemSpider
US2009286847 Patent
View more database links
Registry Number Type Source
75629-57-1 CAS Registry Number ChEBI
Citations Waiting for Citations Types Sources
18794128 PubMed citation SUBMITTER
19208825 PubMed citation SUBMITTER
21443218 PubMed citation Europe PMC
22174819 PubMed citation Europe PMC
25874341 PubMed citation Europe PMC
32019870 PubMed citation Europe PMC
32727562 PubMed citation Europe PMC
33169204 PubMed citation Europe PMC
Last Modified
09 September 2021